Iwona Gisterek

737 citations
51 papers · 427 indexed · 1 hit paper · h-index 11

Iwona Gisterek

40 papers receiving 415 citations

Hit Papers

Temozolomide (TMZ) in the Treatment of Glioblastoma Multi...552024202620251020304050

Peers

Iwona Gisterek
Comparison fields: 5 of 83
  • Cancer Research 112
  • Oncology 183
  • Otorhinolaryngology 18
  • Immunology 86
  • Genetics 27
Replace Chuanming Zheng with:
Chuanming Zheng China
Z Chen United States
Matthias Neid Germany
Wenjing Yang China
Ioannis Gkouveris United States
Julien Lesage France
Daxing Zhu China
Mary E. Rothstein United States
Iwona Gisterek relative to Chuanming Zheng China Chuanming Zheng's profile →
Citations per field
00.5×4.8×
Chuanming Zheng · 1×
Citations per year

Countries citing papers authored by Iwona Gisterek

Since Specialization
Citations

This map shows the geographic impact of Iwona Gisterek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iwona Gisterek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iwona Gisterek more than expected).

Fields of papers citing papers by Iwona Gisterek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iwona Gisterek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iwona Gisterek. The network helps show where Iwona Gisterek may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Iwona Gisterek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iwona Gisterek Line = papers co-authored together Iwona Gisterek links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20240
5
Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomesbreakdown →
202455
6 20240
7 20230
8 202316
9 20232
10 202121
11 20211
12 20203
13 20111
14 20113
15 201112
16 20104
17
The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.
200996
18 200928
19 20079
20
Primary Hodgkin lymphoma located in the base of the tongue (a case report)
20061

About Iwona Gisterek

Iwona Gisterek is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 51 papers that have together received 427 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), Breast Cancer Treatment Studies (8 papers), Immunotherapy and Immune Responses (6 papers), Digital Radiography and Breast Imaging (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Treatment and Pharmacology (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and AI in cancer detection (4 papers). The work is most often cited by research in Cancer Research (112 citations), Oncology (183 citations) and Otorhinolaryngology (18 citations). Iwona Gisterek has collaborated with scholars based in Poland and United States. Frequent co-authors include Jan Kornafel, Rafał Matkowski, Jolanta Szelachowska, Aleksandra Łacko, Agnieszka Hałoń, Marek Pudełko, B. Szynglarewicz, Piotr Dzięgiel, Michał Jeleń and Joanna Katarzyna Strzelczyk.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026